CX3CR1 and neoplasm: However, CX3CR1+ subsets of CD90.1+ CD8+ Pmel-1 T cells were present in the tumors of FTY720-treated mice, suggesting that differentiation of CX3CR1+ CD8+ T cells occurs in the tumor and does not require the migration of CX3CR1− CD8+ T cells to secondary lymphoid organs.